Skip to content
The Policy VaultThe Policy Vault

Levofloxacin injection — CareFirst (Caremark)

Acute pyelonephritis caused by Escherichia coli, including cases with concurrent bacteremia

Initial criteria

  • Reserve levofloxacin injection for treatment of uncomplicated urinary tract infection in patients who have no alternative treatment options
  • Reserve levofloxacin injection for treatment of acute bacterial exacerbation of chronic bronchitis in patients who have no alternative treatment options
  • Reserve levofloxacin injection for treatment of acute bacterial sinusitis in patients who have no alternative treatment options
  • Appropriate culture and susceptibility tests should be performed before treatment when possible
  • Use only to treat or prevent infections proven or strongly suspected to be caused by susceptible bacteria